Skip Nav Destination
A small proportion of mesenchymal stem cells strongly expresses functionally active CXCR4 receptor capable of promoting migration to bone marrow
Gene expression profiles at diagnosis in de novo childhood AML patients identify FLT3 mutations with good clinical outcomes
Imatinib mesylate (STI571) for treatment of children with Philadelphia chromosome-positive leukemia: results from a Children's Oncology Group phase 1 study
Prognostic and biologic significance of chromosomal imbalances assessed by comparative genomic hybridization in multiple myeloma
Myeloablative radiochemotherapy followed by autologous stem cell transplantation in first remission prolongs progression-free survival in follicular lymphoma: results of a prospective, randomized trial of the German Low-Grade Lymphoma Study Group
Comparison of initial characteristics and long-term outcome of patients with lymphocyte-predominant Hodgkin lymphoma and classical Hodgkin lymphoma at clinical stages IA and IIA prospectively treated by brief anthracycline-based chemotherapies plus extended high-dose irradiation
Effect of vitamin K intake on the stability of oral anticoagulant treatment: dose-response relationships in healthy subjects
Strong expression of FOXP1 identifies a distinct subset of diffuse large B-cell lymphoma (DLBCL) patients with poor outcome
Protease inhibitors potentiate chemotherapy-induced neutropenia
Issue Archive
November 1 2004
Table of Contents
INSIDE BLOOD
BLOOD WORK
REVIEW ARTICLES
CHEMOKINES
A small proportion of mesenchymal stem cells strongly expresses functionally active CXCR4 receptor capable of promoting migration to bone marrow
Clinical Trials & Observations
Robert F. Wynn,Claire A. Hart,Carla Corradi-Perini,Liam O'Neill,Caroline A. Evans,J. Ed Wraith,Leslie J. Fairbairn,Ilaria Bellantuono
CLINICAL OBSERVATIONS, INTERVENTIONS, AND THERAPEUTIC TRIALS
Gene expression profiles at diagnosis in de novo childhood AML patients identify FLT3 mutations with good clinical outcomes
Clinical Trials & Observations
Norman J. Lacayo,Soheil Meshinchi,Paivi Kinnunen,Ron Yu,Yan Wang,Christianna M. Stuber,Lorrie Douglas,Romina Wahab,David L. Becton,Howard Weinstein,Myron N. Chang,Cheryl L. Willman,Jerald P. Radich,Robert Tibshirani,Yaddanapudi Ravindranath,Branimir I. Sikic,Gary V. Dahl
Imatinib mesylate (STI571) for treatment of children with Philadelphia chromosome-positive leukemia: results from a Children's Oncology Group phase 1 study
Clinical Trials & Observations
Martin A. Champagne,Renaud Capdeville,Mark Krailo,Wenchun Qu,Bin Peng,Marianne Rosamilia,Martine Therrien,Ulrike Zoellner,Susan M. Blaney,Mark Bernstein
Prognostic and biologic significance of chromosomal imbalances assessed by comparative genomic hybridization in multiple myeloma
Clinical Trials & Observations
Norma C. Gutiérrez,Juan L. García,Jesús M. Hernández,Eva Lumbreras,Mariana Castellanos,Ana Rasillo,Gema Mateo,José M. Hernández,Sonia Pérez,Alberto Orfao,Jesús F. San Miguel
Myeloablative radiochemotherapy followed by autologous stem cell transplantation in first remission prolongs progression-free survival in follicular lymphoma: results of a prospective, randomized trial of the German Low-Grade Lymphoma Study Group
Clinical Trials & Observations
Georg Lenz,Martin Dreyling,Eva Schiegnitz,Roswitha Forstpointner,Hannes Wandt,Mathias Freund,Georg Hess,Lorenz Truemper,Volker Diehl,Martin Kropff,Michael Kneba,Norbert Schmitz,Bernd Metzner,Markus Pfirrmann,Michael Unterhalt,Wolfgang Hiddemann
Comparison of initial characteristics and long-term outcome of patients with lymphocyte-predominant Hodgkin lymphoma and classical Hodgkin lymphoma at clinical stages IA and IIA prospectively treated by brief anthracycline-based chemotherapies plus extended high-dose irradiation
Clinical Trials & Observations
Pierre Feugier,Eric Labouyrie,Malika Djeridane,Arash Jenabian,Viviane Dubruille,Christian Berthou,Christiane Ghandour,Bernard Desablens,Yasmine Chaït,Philippe Casassus,Vincent Delwail,Norbert Ifrah,Annick Le Mevel,Thierry Lamy,Josette Brière,Pierre Colonna,Jean-Marie Andrieu
Effect of vitamin K intake on the stability of oral anticoagulant treatment: dose-response relationships in healthy subjects
Clinical Trials & Observations
Improved outcome for children with acute lymphoblastic leukemia: results of Total Therapy Study XIIIB at St Jude Children's Research Hospital
Ching-Hon Pui,John T. Sandlund,Deqing Pei,Dario Campana,Gaston K. Rivera,Raul C. Ribeiro,Jeffrey E. Rubnitz,Bassem I. Razzouk,Scott C. Howard,Melissa M. Hudson,Cheng Cheng,Larry E. Kun,Susana C. Raimondi,Frederick G. Behm,James R. Downing,Mary V. Relling,William E. Evans
GENE THERAPY
Permanent phenotypic correction of hemophilia B in immunocompetent mice by prenatal gene therapy
Simon N. Waddington,Megha S. Nivsarkar,Ajay R. Mistry,Suzanne M. K. Buckley,Geoffrey Kemball-Cook,Karen L. Mosley,Kyriacos Mitrophanous,Pippa Radcliffe,Maxine V. Holder,Mairi Brittan,Anastasios Georgiadis,Faisal Al-Allaf,Brian W. Bigger,Lisa G. Gregory,H. Terence Cook,Robin R. Ali,Adrian Thrasher,Edward G. D. Tuddenham,Mike Themis,Charles Coutelle
HEMATOPOIESIS
HEMOSTASIS, THROMBOSIS, AND VASCULAR BIOLOGY
IMMUNOBIOLOGY
NEOPLASIA
Subsets with restricted immunoglobulin gene rearrangement features indicate a role for antigen selection in the development of chronic lymphocytic leukemia
Gerard Tobin,Ulf Thunberg,Karin Karlsson,Fiona Murray,Anna Laurell,Kerstin Willander,Gunilla Enblad,Mats Merup,Juhani Vilpo,Gunnar Juliusson,Christer Sundström,Ola Söderberg,Göran Roos,Richard Rosenquist
Real-time quantitative PCR analysis can be used as a primary screen to identify patients with CML treated with imatinib who have BCR-ABL kinase domain mutations
Susan Branford,Zbigniew Rudzki,Ian Parkinson,Andrew Grigg,Kerry Taylor,John F. Seymour,Simon Durrant,Peter Browett,Anthony P. Schwarer,Chris Arthur,John Catalano,Michael F. Leahy,Robin Filshie,Kenneth Bradstock,Richard Herrmann,David Joske,Kevin Lynch,Tim Hughes
Strong expression of FOXP1 identifies a distinct subset of diffuse large B-cell lymphoma (DLBCL) patients with poor outcome
Clinical Trials & Observations
Brief Report
Protease inhibitors potentiate chemotherapy-induced neutropenia
Clinical Trials & Observations
Brief Report
Mark Bower,Neil McCall-Peat,Natalie Ryan,Liz Davies,Anne Marie Young,Srirupa Gupta,Mark Nelson,Brian Gazzard,Justin Stebbing
PHAGOCYTES
RED CELLS
TRANSPLANTATION
CORRESPONDENCE
-
Cover Image
Cover Image
Advertisement
Email alerts
Advertisement